This contrasts with findings by Wang et al
Along with unexpected benefits, medical specialists in South Florida also see patients grappling with the drawbacks of GLP-1 use
Purely from a value perspective, we should be even more underallocating here, but I feel that we might be betting on Novo Nordisk a bit too much
Skin Rejuvenation : Leaves the skin smoother, softer, and visibly brighter
a RWD: real-world data from cohort or registry studies (electronic health records, insurance-claims databases), b SRS: adverse drug reaction evidence from case reports and spontaneous-reporting systems, such as the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and World Health Organization (WHO) VigiBase
Understanding how each one functionsand which may be a better fit for your needscomes down to more than just popularity